Ro Body Tirzepatide Review
Released: Last reviewed: NexLife pricing verified: Ro Body data verified: Updated:
Ro is one of the original DTC telehealth platforms. Ro Body offers brand-name Zepbound and Mounjaro with insurance prior-authorization assistance. MD-led intake, well-resourced support team. Best for insured patients or cash-pay patients willing to pay brand-name prices.
Ro Body at a glance
| Pricing | semaglutide oral $298/mo all-in (brand); tirzepatide pen $448/mo all-in (brand) |
|---|---|
| Pharmacy | Brand Lilly pharmacy |
| Clinician | MD |
| States | 50 states |
| Editorial score | 84 / 100 |
About Ro Body
Ro Body (formerly known simply as Ro) operates one of the largest direct-to-consumer telehealth platforms in the United States, with broad medication offerings spanning men's health, women's health, weight management, and chronic care. The Ro Body weight-loss program offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) along with personalized coaching and labs.
Clinical & business model
Ro emphasizes a brand-name-first model — patients are placed on FDA-approved GLP-1s where insurance permits. Pricing is described as a combined membership covering provider visits, ongoing care, and prescription routing, with medication priced separately through pharmacy or insurance.
What Ro Body does well
- Large-scale platform with established operational infrastructure
- Brand-name medication access with insurance coordination
- Mobile-first patient experience
- Broad multi-condition offering beyond GLP-1s
Trade-offs to consider
- Medication cost is typically not bundled into a flat rate; total cost can vary widely based on insurance and chosen drug
- Less emphasis on compounded options for cost-sensitive patients
- Brand positioning is consumer-focused; clinical oversight depth varies by program
Who Ro Body is best for
Patients who have insurance coverage for brand-name GLP-1s and prefer working with a well-known direct-to-consumer brand.
How it compares to NexLife (our #1 pick)
NexLife (94/100) outranks Ro Body on self-pay pricing from $139/month with a 12-month plan all-inclusive on the 12-month plan), named dispensing pharmacies, and MD/DO-supervised clinical model. Ro Body is a stronger fit for insurance-bundled brand-name access; NexLife is a stronger fit for cash-pay compounded programs with predictable cost.
Frequently asked questions
Is Ro Body the same as Ro?
Ro Body is the weight management arm of Ro, the broader direct-to-consumer health platform. Other Ro programs include Ro Sex, Ro Hair, and Ro Mind.
Does Ro Body accept insurance?
Ro coordinates with insurance for brand-name GLP-1 coverage where the patient's plan permits. Patients without coverage typically pay cash for the medication separately from the Ro membership.
What pharmacies does Ro Body use?
Ro coordinates with retail pharmacies in the patient's area for brand-name dispensing, and has historically partnered with specific compounding pharmacies for certain offerings. Specific pharmacy disclosure varies.
NexLife Tirzepatide
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
- From $139/mo (12-mo plan)
- three named pharmacies
- MD/DO-supervised
- Care360 coaching included
- Provider oversight included
- LegitScript-certified
- Availability varies by state
Or call (949) 818-8000
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022